Skip to main content
x
Dartmouth-Hitchcock logo
Summer Flowers In This Section

Assessment of the WATCHMAN Device in Patients Unsuitable for Oral Anticoagulation

Principal Investigator

Megan Coylewright

Study Number

F18061

Summary

This is a study for people with atrial fibrillation AFib, a heart condition in which the upper chambers of the heart beat irregularly, and who cannot take blood thinners (also known as anticoagulation medicines). Patients with AFib are at risk for blood clots forming in a space in the heart called the Left Arterial Appendage (LAA). The Watchman device is used to close off the LAA, which reduces the chances of blood clots. The Watchman device is only FDA approved when used along with blood thinners. This study will evaluate the use of the Watchman device in patients that cannot tolerate blood thinners.

Phase

Phase III

Contact

Hannah Ellis

Available at the following location(s)

  • Lebanon

View more details at ClinicalTrials.gov

Do you need help with some of the labels on this page?
Read our glossary of terms

0